Skip to main content

Lanreotide Acetate

NDC 69097-870 · Cipla USA Inc.

Generic namelanreotide acetate
Dosage formINJECTION
RouteSUBCUTANEOUS
Active ingredient(s)LANREOTIDE ACETATE
Strength120 mg/.5mL
Pharmacologic classSomatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
Marketing categoryNDA

Packages

69097-870-67 — 1 SYRINGE in 1 CARTON (69097-870-67) / .5 mL in 1 SYRINGE

Billed under HCPCS

J1932 — Injection, lanreotide, (cipla), 1 mg Medicare Part B payment limit (ASP + 6%): $20.33

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

15054-1060 — lanreotide acetate, 15054-1090 — lanreotide acetate, 15054-1120 — lanreotide acetate, 69097-880 — lanreotide acetate, 69097-890 — lanreotide acetate, 69097-906 — LANREOTIDE ACETATE, 69097-907 — LANREOTIDE ACETATE, 69097-908 — LANREOTIDE ACETATE, 76282-718 — LANREOTIDE ACETATE, 76282-719 — LANREOTIDE ACETATE, 76282-720 — LANREOTIDE ACETATE

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.